We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Dr. Reddy’s was dealt a huge setback in its quest to market a generic version of Pfizer’s Norvasc (amlodipine besylate) Friday when a federal appeals court judge overturned a lower court decision dismissing Pfizer’s claims that Dr. Reddy’s product infringed their patent.
A generic subsidiary of Novartis has filed an antitrust claim against GlaxoSmithKline (GSK) over patents related to Augmentin, GSK revealed Feb. 11 in its 2003 earnings report.
Israeli generic firm Dexxon has been sued by GlaxoSmithKline (GSK) in Israel to stop marketing a version of GSK’s indigestion drug Zantac (ranitidine HCl) under the similar trademark Zanidex.
Two health insurers have filed an antitrust lawsuit against Purdue Pharma for allegedly blocking generic competition against the firm’s pain treatment OxyContin (oxycodone).
Drugmakers cannot hope for judicial relief if the Centers for Medicare & Medicaid Services (CMS) cuts Medicare hospital outpatient reimbursements for their products, even if it does so by eliminating statutorily mandated pass-through payments for new drugs, a federal court has ruled.
GlaxoSmithKline (GSK) revealed in its 2003 earnings report last week that federal investigators are looking into sales and promotional practices of a number of its biggest-selling products over the past seven years.
Drugmakers cannot hope for judicial relief if the Centers for Medicare & Medicaid Services (CMS) cuts Medicare hospital outpatient reimbursements for their products, even if it does so by eliminating statutorily mandated pass-through payments for new drugs, a federal court has ruled.
Federal investigators are looking into GlaxoSmithKline’s (GSK’s) sales and promotional practices for a number of its biggest-selling products for the past seven years, the drugmaker revealed Wednesday in its 2003 earnings report.